# Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]

> **NCT04059887** · PHASE4 · COMPLETED · sponsor: **Chonnam National University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Lung Neoplasm Malignant

## Interventions

- **DRUG:** Atezolizumab Injection [Tecentriq]

## Key facts

- **NCT ID:** NCT04059887
- **Lead sponsor:** Chonnam National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-18
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04059887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04059887, "Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04059887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*